Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2017

13.10.2017 | Editorial

Modulation of Gut Microbiota by Maillard Reaction Products in Intestinal Inflammation: Are We What We Eat?

verfasst von: Adam Fabisiak

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Excerpt

Although “We are what we eat” is a popular phrase implying that eating certain foods affects one’s health, the phrase is currently gaining scientific credence due to the discovery of the linkage between diet, the intestinal microbiome, and many diseases. Disease entities not only limited to the gastrointestinal (GI) tract are described as microbiota-dependent. As an example, inflammatory bowel disease (IBD) possesses an established etiopathogenesis which comprises the genetic susceptibility and environmental factors associated with changes in the intestinal microbiota. The increasing incidence of IBD correlates with overall global industrialization, which in turn correlates with the “Western pattern diet” [1]. …
Literatur
2.
Zurück zum Zitat ALJahdali N, Gadonna-Widehem P, Delayre-Orthez C, et al. Repeated oral exposure to N ε-carboxymethyllysine, a Maillard reaction product, alleviates gut microbiota dysbiosis in colitic mice. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-017-4767-8. ALJahdali N, Gadonna-Widehem P, Delayre-Orthez C, et al. Repeated oral exposure to N ε-carboxymethyllysine, a Maillard reaction product, alleviates gut microbiota dysbiosis in colitic mice. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-017-4767-8.
3.
Zurück zum Zitat Delgado-Andrade C. Maillard reaction products: some considerations on their health effects. Clin Chem Lab Med. 2014;52:53–60.CrossRefPubMed Delgado-Andrade C. Maillard reaction products: some considerations on their health effects. Clin Chem Lab Med. 2014;52:53–60.CrossRefPubMed
Metadaten
Titel
Modulation of Gut Microbiota by Maillard Reaction Products in Intestinal Inflammation: Are We What We Eat?
verfasst von
Adam Fabisiak
Publikationsdatum
13.10.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4796-3

Weitere Artikel der Ausgabe 12/2017

Digestive Diseases and Sciences 12/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.